Development of Imminent Mortality Predictor for Advanced Cancer (IMPAC), a Tool to Predict Short-Term Mortality in Hospitalized Patients With Advanced Cancer.

MLA

Adelson, Kerin, et al. “Development of Imminent Mortality Predictor for Advanced Cancer (IMPAC), a Tool to Predict Short-Term Mortality in Hospitalized Patients With Advanced Cancer.” Journal of Oncology Practice, vol. 14, no. 3, Mar. 2018, pp. e168–75. EBSCOhost, https://doi.org/10.1200/JOP.2017.023200.

APA

Adelson, K., Lee, D. K. K., Velji, S., Ma, J., Lipka, S. K., Rimar, J., Longley, P., Vega, T., Perez-Irizarry, J., Pinker, E., & Lilenbaum, R. (2018). Development of Imminent Mortality Predictor for Advanced Cancer (IMPAC), a Tool to Predict Short-Term Mortality in Hospitalized Patients With Advanced Cancer. Journal of Oncology Practice, 14(3), e168–e175. https://doi.org/10.1200/JOP.2017.023200

Chicago

Adelson, Kerin, Donald K K Lee, Salimah Velji, Junchao Ma, Susan K Lipka, Joan Rimar, Peter Longley, et al. 2018. “Development of Imminent Mortality Predictor for Advanced Cancer (IMPAC), a Tool to Predict Short-Term Mortality in Hospitalized Patients With Advanced Cancer.” Journal of Oncology Practice 14 (3): e168–75. doi:10.1200/JOP.2017.023200.